Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and upregulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
Remyelination: The True Regeneration of the Central Nervous System.
Gateway to wellness: an occupational therapy collaboration with the national multiple sclerosis society.
Erythrocyte membrane Fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils.
Glutamate inhibition in MS: the neuroprotective properties of riluzole.
Iranian family caregivers' challenges and issues in caring of multiple sclerosis patients: A descriptive explorative qualitative study.
Cortico-juxtacortical involvement increases risk of epileptic seizures in multiple sclerosis.
The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis.
Type 1 immune response in progressive multiple sclerosis.
Personality characteristics in MS patients: The role of avoidant personality.
"People power" or "pester power"? YouTube as a forum for the generation of evidence and patient advocacy.
Glycans of myelin proteins.
Towards programming immune tolerance through geometric manipulation of phosphatidylserine.
Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.
Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.
Role of Venoplasty for Treatment of Multiple Sclerosis: Value of Open-label Studies and Surrogate Treatment Outcomes.
Aging and multiple sclerosis.
A case of septal panniculitis secondary to interferon treatment.
Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue.
The Development and Maintenance of Paclitaxel-Induced Neuropathic Pain Requires Activation of the Sphingosine 1-Phosphate Receptor Subtype 1.
Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
Extracting quantitative measures from EAP: a small clinical study using BFOR.
Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
233
234
235
236
237
238
239
240
241
…
next ›
last »